Covagen Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Covagen General Information

Description

Operator of a biopharmaceutical company intended to focus on therapies for inflammatory diseases and cancer. The company develops a proprietary platform that genetically fuses Fynomer-binding proteins to antibodies, resulting in therapeutics with novel modes of action, enabling clients to facilitate the treatment of rheumatoid arthritis, psoriatic arthritis, and other inflammatory diseases.

Contact Information

Website
covagen.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Wagistrasse 25
  • 8952 Zurich
  • Switzerland
+41 044
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Cilag
Vertical(s)
Corporate Office
  • Wagistrasse 25
  • 8952 Zurich
  • Switzerland
+41 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 25-Aug-2014 Completed Pre-Clinical Trials
7. Later Stage VC (Series B) 09-Dec-2013 Completed Pre-Clinical Trials
6. Early Stage VC (Series A) 29-Nov-2010 Completed Startup
5. Early Stage VC 08-Jan-2010 Completed Startup
4. Seed Round 07-Jan-2010 Completed Startup
3. Accelerator/Incubator 01-Jan-2006 Completed Startup
2. University Spin-Out 01-Jan-2006 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Covagen’s complete valuation and funding history, request access »

Covagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to focus on therapies for inflammatory diseases and cancer. The company
Drug Discovery
Zurich, Switzerland

Lebanon, NH
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Covagen Competitors (111)

One of Covagen’s 111 competitors is Adimab, a Venture Capital-Backed company based in Lebanon, NH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adimab Venture Capital-Backed Lebanon, NH
Annexon Biosciences Formerly VC-backed Brisbane, CA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Solid Biosciences Formerly VC-backed Charlestown, MA
TME Pharma Formerly VC-backed Berlin, Germany
You’re viewing 5 of 111 competitors. Get the full list »

Covagen Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority
Ascent Biomedical Ventures Venture Capital Minority
Baxter Ventures Corporate Venture Capital Minority
Gimv PE/Buyout Minority
MP Healthcare Venture Management Corporate Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Covagen FAQs

  • When was Covagen founded?

    Covagen was founded in 2006.

  • Where is Covagen headquartered?

    Covagen is headquartered in Zurich, Switzerland.

  • What industry is Covagen in?

    Covagen’s primary industry is Drug Discovery.

  • Is Covagen a private or public company?

    Covagen is a Private company.

  • What is Covagen’s current revenue?

    The current revenue for Covagen is .

  • How much funding has Covagen raised over time?

    Covagen has raised $94M.

  • Who are Covagen’s investors?

    Andera Partners, Ascent Biomedical Ventures, Baxter Ventures, Gimv, and MP Healthcare Venture Management are 5 of 10 investors who have invested in Covagen.

  • Who are Covagen’s competitors?

    Adimab, Annexon Biosciences, CytomX Therapeutics, Solid Biosciences, and TME Pharma are some of the 111 competitors of Covagen.

  • When was Covagen acquired?

    Covagen was acquired on 25-Aug-2014.

  • Who acquired Covagen?

    Covagen was acquired by Cilag.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process